DNA Damage-Mediated Induction of a Chemoresistant Niche

Cited by (428)

Items 101–200 of 428

1. Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD‐L1)‐mediated immunosuppression
   Qixia Xu, Qilai Long, Dexiang Zhu, Da Fu, Boyi Zhang, Liu Han, Min Qian, Jianming Guo, Jianmin Xu, Liu Cao et al. · 2019 · Aging Cell
2. Tumor heterogeneity in the clinic: is it a real problem?
   Filip Jankú · 2013 · Therapeutic Advances in Medical Oncology
3. Tumor microenvironment-mediated chemoresistance in breast cancer
   Kobra Velaei, Nasser Samadi, Balal Brazvan, Jafar Soleimani Rad · 2016 · The Breast
4. Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer
   Shintaro Takeuchi, Muhammad Baghdadi, Takahiro Tsuchikawa, Haruka Wada, Toru Nakamura, Hirotake Abe, Sayaka Nakanishi, Yuu Usui, Kohtaro Higuchi, Mizuna Takahashi et al. · 2015 · Cancer Research
5. Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects
   Yuval Shaked · 2016 · Nature Reviews Clinical Oncology
6. The many faces of Janus kinase
   Matthew M. Seavey, Paweł Dobrzański · 2011 · Biochemical Pharmacology
7. Nucleosidic DNA demethylating epigenetic drugs – A comprehensive review from discovery to clinic
   Khushboo Agrawal, Viswanath Das, Pankhuri Vyas, Marián Hajdúch · 2018 · Pharmacology & Therapeutics
8. Cellular senescence and cancer chemotherapy resistance
   Ryan R. Gordon, Peter S. Nelson · 2012 · Drug Resistance Updates
9. Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells
   Zhongwei Cao, Joseph Michael Scandura, Giorgio Inghirami, Koji Shido, Bi‐Sen Ding, Shahin Rafii · 2016 · Cancer Cell
10. Genetically Engineered Mouse Models: Closing the Gap between Preclinical Data and Trial Outcomes
    Singh, Mallika, Murriel, Christopher L., Johnson, Leisa · 2012 · Cancer Research
11. Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond
    Sven Danckwardt, Matthias W. Hentze, Andreas E. Kulozik · 2013 · Journal of Molecular Medicine
12. Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance
    Yun Che, Jingnan Wang, Yuan Li, Zhiliang Lu, Jianbing Huang, Shouguo Sun, Shuangshuang Mao, Yuanyuan Lei, Ruochuan Zang, Nan Sun et al. · 2018 · Cell Death and Disease
13. Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme
    Jiemiao Hu, Qingnan Zhao, Ling-Yuan Kong, Jian Wang, Jun Yan, Xueqing Xia, Zhiliang Jia, Amy B. Heimberger, Shulin Li · 2021 · Science Advances
14. Cyclodextrin-based host-guest complexes loaded with regorafenib for colorectal cancer treatment
    Hongzhen Bai, Jianwei Wang, Chi Uyen Phan, Qi Chen, Xiu-Rong Hu, Guoqiang Shao, Jun Zhou, Lihua Lai, Guping Tang · 2021 · Nature Communications
15. Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance
    Fei Chen, Qilai Long, Da Fu, Dexiang Zhu, Yan Ji, Liu Han, Boyi Zhang, Qixia Xu, Bingjie Liu, Yan Li et al. · 2018 · Nature Communications
16. STAT3 Is Activated by JAK2 Independent of Key Oncogenic Driver Mutations in Non-Small Cell Lung Carcinoma
    Looyenga, Brendan D., Hutchings, Danielle, Cherni, Irene, Kingsley, Chris, Weiss, Glen J., MacKeigan, Jeffrey P. · 2012 · PLoS ONE
17. Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin
    Lei Miao, Yuhua Wang, C. Michael Lin, Yang Xiong, Naihan Chen, Lu Zhang, William Y. Kim, Leaf Huang · 2015 · Journal of Controlled Release
18. Cancer Metastasis: A Reappraisal of Its Underlying Mechanisms and Their Relevance to Treatment
    Nicolò Riggi, Michel Aguet, Ivan Stamenkovic · 2017 · Annual Review of Pathology Mechanisms of Disease
19. Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer
    Cameron N. Johnstone, Ashwini L. Chand, Tracy L. Putoczki, Matthias Ernst · 2015 · Cytokine & Growth Factor Reviews
20. Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression
    Mu Hao, Li Zhang, Gang An, Hengxing Meng, You-Jin Han, Zhenqing Xie, Yan Xu, Changhong Li, Zhen Yu, Hong Hee Chang et al. · 2011 · Leukemia & lymphoma/Leukemia and lymphoma
21. Stress signaling in breast cancer cells induces matrix components that promote chemoresistant metastasis
    Jacob Insua‐Rodríguez, Maren Pein, Tsunaki Hongu, Jasmin Meier, Arnaud Descot, Camille Lowy, Etienne D. Braekeleer, Hans‐Peter Sinn, Saskia Spaich, Marc Sütterlin et al. · 2018 · EMBO Molecular Medicine
22. Alterations in DNA Damage Repair Genes in Primary Liver Cancer
    Jianzhen Lin, Junping Shi, Honglin Guo, Xu Yang, Yan Jiang, Junyu Long, Yi Bai, Dongxu Wang, Xiaobo Yang, Xueshuai Wan et al. · 2019 · Clinical Cancer Research
23. Dysfunctional endothelial cells directly stimulate cancer inflammation and metastasis
    Joseph Wang Franses, Natalia C. Drosu, William J. Gibson, Vipul Chimanlal Chitalia, Elazer Reuven Edelman · 2013 · International Journal of Cancer
24. αvβ3 Integrin and tumour blood vessels — learning from the past to shape the future
    Fevzi Demircioglu, Kairbaan Hodivala‐Dilke · 2016 · Current Opinion in Cell Biology
25. The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer
    Laura García-Hernández, María Belén García‐Ortega, Gloria Ruiz-Alcalá, Esmeralda Carrillo, Juan Antonio Marchal, María Ángel García · 2021 · International Journal of Molecular Sciences
26. Modeling and predicting clinical efficacy for drugs targeting the tumor milieu
    Mallika Singh, Napoleone Ferrara · 2012 · Nature Biotechnology
27. Molecular Pathways: Endothelial Cell FAK—A Target for Cancer Treatment
    Marina Roy-Luzarraga, Kairbaan Hodivala‐Dilke · 2016 · Clinical Cancer Research
28. Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells
    Ping‐Pui Wong, José M. Muñoz‐Félix, Maruan Hijazi, Hyo-Jin Kim, Stephen David Robinson, Beatriz de Luxán‐Delgado, Irene Rodríguez‐Hernández, Óscar Maiques, Ya-Ming Meng, Qiong Meng et al. · 2020 · Cell
29. Endothelial Interleukin-6 Defines the Tumorigenic Potential of Primary Human Cancer Stem Cells
    Sudha Krishnamurthy, Kristy A. Warner, Zhihong Dong, Atsushi Imai, Carolina Nör, Brent Benson Ward, Joseph I. Helman, Russell S. Taichman, Emily Light Bellile, Laurie K. McCauley et al. · 2014 · Stem Cells
30. Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia
    Huimin Geng, Sarah K. Brennan, Thomas A. Milne, Wei‐Yi Chen, Yushan Li, Christian Hurtz, Soo-Mi Kweon, Lynette Zickl, Seyedmehdi Shojaee, Donna S Neuberg et al. · 2012 · Cancer Discovery
31. Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group
    Vindi Jurinović, Bernd Metzner, Michael G. Pfreundschuh, Norbert Schmitz, Hannes Wandt, Ulrich Bernd Keller, Peter Dreger, Martin H. Dreyling, Wolfgang Hiddemann, Michael Unterhalt et al. · 2018 · Transplantation and Cellular Therapy
32. Cellular Constituents of the Prostate Stroma: Key Contributors to Prostate Cancer Progression and Therapy Resistance
    Christine Levesque, Peter S. Nelson · 2017 · Cold Spring Harbor Perspectives in Medicine
33. How to escape the cancer attractor: Rationale and limitations of multi-target drugs
    Sui Huang, Stuart Alan Kauffman · 2013 · Seminars in Cancer Biology
34. Chemopreventive Potential of Caryophyllane Sesquiterpenes: An Overview of Preliminary Evidence
    Antonella Di Sotto, Romina Mancinelli, Marco Gullì, Margherita Eufemi, Caterina Loredana Mammola, Gabriela Mazzanti, Silvia Di Giacomo · 2020 · Cancers
35. Cellular senescence: from growth arrest to immunogenic conversion
    Dominick G. A. Burton, Richard Faragher · 2015 · AGE
36. Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma
    Teppei Jinno, Shintaro Kawano, Yasuyuki Maruse, Ryota Matsubara, Yuichi Goto, Taiki Sakamoto, Yuma Hashiguchi, Naoki Kaneko, Hideaki Tanaka, Ryoji Kitamura et al. · 2015 · Oncology Reports
37. Chemotherapy-Exacerbated Breast Cancer Metastasis: A Paradox Explainable by Dysregulated Adaptive-Response
    Justin D. Middleton, Daniel G. Stover, Tsonwin Hai · 2018 · International Journal of Molecular Sciences
38. A Galectin-3–Dependent Pathway Upregulates Interleukin-6 in the Microenvironment of Human Neuroblastoma
    Silverman, Ayaka M., Nakata, Rie, Shimada, Hiroyuki, Sposto, Richard, DeClerck, Yves A. · 2012 · Cancer Research
39. Inflamm‐aging of the stem cell niche: Breast cancer as a paradigmatic example
    Massimiliano Bonafè, Gianluca Storci, Claudio Franceschi · 2011 · BioEssays
40. New cast for a new era: preclinical cancer drug development revisited
    Grit Sophie Herter-Sprie, Andrew L. Kung, Kwok‐Kin Wong · 2013 · Journal of Clinical Investigation
41. CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer
    Weilong Chen, Yuanyuan Qin, Dong Wang, Lei Zhou, Yin Liu, Sheng Chen, Liang Yin, Yaoxing Xiao, Xiao-Hong Yao, Xiao‐Li Yang et al. · 2018 · PLoS Biology
42. The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure
    Claudia Galassi, Martina Musella, Nicoletta Manduca, Ester Maccafeo, Antonella Sistigu · 2021 · Cells
43. SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis
    Shuang Dai, Yuanliang Yan, Zhijie Xu, Shuangshuang Zeng, Long Qian, Lei Huo, Xuejun Li, Lun‐Quan Sun, Zhicheng Gong · 2018 · Frontiers in Pharmacology
44. IL6 Modulates the Immune Status of the Tumor Microenvironment to Facilitate Metastatic Colonization of Colorectal Cancer Cells
    Yujiro Toyoshima, Hidemitsu Kitamura, Huihui Xiang, Yosuke Ohno, Shigenori Homma, Hideki Kawamura, Norihiko Takahashi, Toshiya Kamiyama, Mishie Ann Tanino, Akinobu Taketomi · 2019 · Cancer Immunology Research
45. Translational Horizons in the Tumor Microenvironment: Harnessing Breakthroughs and Targeting Cures
    Yu Sun · 2015 · Medicinal Research Reviews
46. Cellular senescence and aging: the role of B‐ MYB
    Sophia N. Mowla, Eric W.‐F. Lam, Parmjit Jat · 2014 · Aging Cell
47. Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional study
    Daniel DiCenzo, Karina Quiaoit, Kashuf Fatima, Divya Bhardwaj, Lakshmanan Sannachi, Mehrdad J. Gangeh, Ali Sadeghi Naini, Archya Dasgupta, Michael C. Kolios, Maureen Trudeau et al. · 2020 · Cancer Medicine
48. Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance
    Jianing Gong, Taoran Shi, Jinfeng Liu, Zerong Pei, Jingbo Liu, Xiaoliang Ren, Fengyun Li, Feng Qiu · 2023 · Biomedicine & Pharmacotherapy
49. p38 MAPK Controls Prothrombin Expression by Regulated RNA 3′ End Processing
    Sven Danckwardt, Anne-Susan Gantzert, Stephan Macher‐Goeppinger, Hans Christian Probst, Marc Gentzel, Matthias S. Wilm, Hermann‐Josef Gröne, Peter Schirmacher, Matthias W. Hentze, Andreas E. Kulozik · 2011 · Molecular Cell
50. Regulatory players of DNA damage repair mechanisms: Role in Cancer Chemoresistance
    Kunnathur Murugesan Sakthivel, Sreedharan Hariharan · 2017 · Biomedicine & Pharmacotherapy
51. CDK8 kinase—An emerging target in targeted cancer therapy
    Tomasz Rzymski, Michał Mikuła, Katarzyna Wiklik, Krzysztof D. Brzózka · 2015 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
52. When the Damage Is Done: Injury and Repair in Thymus Function
    Sinead M. Kinsella, Jarrod A. Dudakov · 2020 · Frontiers in Immunology
53. Tumour Microenvironment Stress Promotes the Development of Drug Resistance
    Nicole A. Seebacher, Mária Krchniaková, Alexandra E. Stacy, Jan Skoda, Patric J. Jansson · 2021 · Antioxidants
54. Smart Drug Delivery System
    Ali Demir Sezer · 2016 · InTech eBooks
55. Interactions between cancer stem cells, immune system and some environmental components: Friends or foes?
    Vahidian, Fatemeh, Duijf, Pascal H.G., Safarzadeh, Elham, Derakhshani, Afshin, Baghbanzadeh, Amir, Baradaran, Behzad · 2019 · Immunology Letters
56. Therapeutic targeting of replicative immortality
    Paul Yaswen, Karen L. MacKenzie, W. Nicol Keith, Patricia Hentosh, Françis Rodier, Jiyue Zhu, Gary L. Firestone, Ander Matheu, Amancio Carnero, Alan E Bilsland et al. · 2015 · Seminars in Cancer Biology
57. Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma
    Schoetz, Ulrike, Klein, Diana, Hess, Julia, Shnayien, Seyd, Spoerl, Steffen, Orth, Michael, Mutlu, Samet, Hennel, Roman, Sieber, Anja, Ganswindt, Ute et al. · 2021 · Cell Death & Disease
58. Molecular Pathways: Involving Microenvironment Damage Responses in Cancer Therapy Resistance
    Yu Sun, Peter S. Nelson · 2012 · Clinical Cancer Research
59. The senescence journey in cancer immunoediting
    Alessandra Zingoni, Fabrizio Antonangeli, Silvano Sozzani, Angela Santoni, Marco Cippitelli, Alessandra Soriani · 2024 · Molecular Cancer
60. Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges
    Zhenyu Nie, Mei Chen, Yuanhui Gao, Denggao Huang, Hui Cao, Yanling Peng, Na Guo, Fei Wang, Shufang Zhang · 2022 · Frontiers in Pharmacology
61. Targeting S100A9–ALDH1A1–Retinoic Acid Signaling to Suppress Brain Relapse in EGFR -Mutant Lung Cancer
    Anup Kumar Biswas, Seoyoung Han, Yifan Tai, Wanchao Ma, Courtney Coker, S. Aidan Quinn, Ahmad Rushdi Shakri, Timothy James Zhong, Hanna Scholze, Galina G. Lagos et al. · 2022 · Cancer Discovery
62. Premature aging/senescence in cancer cells facing therapy: good or bad?
    Llilians Calvo, Sabrina Ghadaouia, Aurélie Martinez, Françis Rodier · 2015 · Biogerontology
63. Cancer Stem-like Cells Derived from Chemoresistant Tumors Have a Unique Capacity to Prime Tumorigenic Myeloid Cells
    Tsunaki Yamashina, Muhammad Baghdadi, Akihiro Yoneda, Ichiro Kinoshita, Shinya Suzu, Hirotoshi Dosaka‐Akita, Masahisa Jinushi · 2014 · Cancer Research
64. DNA damage induces the IL-6/STAT3 signaling pathway, which has anti-senescence and growth-promoting functions in human tumors
    Yun, Un Jung, Park, Sang Eun, Jo, Yong Sam, Kim, Jungbin, Shin, Deug Y. · 2012 · Cancer Letters
65. Three-dimensional bio-printing: A new frontier in oncology research
    Nitin B. Charbe, Paul A. McCarron, Murtaza M. Tambuwala · 2017 · World Journal of Clinical Oncology
66. Drug screening in Drosophila; why, when, and when not?
    Tin Tin Su · 2019 · Wiley Interdisciplinary Reviews Developmental Biology
67. Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers
    Jhih-Ying Chi, Yu‐Wei Hsiao, Chien‐Feng Li, Yu-Chih Lo, Zu‐Yau Lin, Jhen‐Yi Hong, Yang-Ming Liu, Xiu Han, Shao‐Ming Wang, Ben‐Kuen Chen et al. · 2015 · Oncotarget
68. Harnessing Tumor Evolution to Circumvent Resistance
    Katherine Lee McNamara, Christina N. Curtis · 2018 · Trends in Genetics
69. Circulating tumor cell profiling for precision oncology
    Mahmoud Labib, Shana O. Kelley · 2021 · Molecular Oncology
70. M2 tumor-associated macrophages produce interleukin-17 to suppress oxaliplatin-induced apoptosis in hepatocellular carcinoma
    Bin Guo, Leilei Li, Jiapei Guo, Aidong Liu, Jinghua Wu, Haixin Wang, Jun Shi, Dequan Pang, Qing Cao · 2017 · Oncotarget
71. Dual role of quercetin in enhancing the efficacy of cisplatin in chemotherapy and protection against its side effects: a review
    Masoud Najafi, Shima Tavakol, Ali Zarrabi, Milad Ashrafizadeh · 2020 · Archives of Physiology and Biochemistry
72. Radiotherapy-induced remodeling of the tumor microenvironment by stromal cells
    Tracy J. Berg, Alexander Pietras · 2022 · Seminars in Cancer Biology
73. Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?
    Yue Liu, Isabelle Lomeli, Stephen J. Kron · 2024 · Cells
74. Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer
    Zenobia D’Costa, Keaton Ian Jones, Abul Kalam Azad, Ruud G.P.M. van Stiphout, Su Yin Lim, Ana L. Gomes, Paul Kinchesh, Sean Smart, William Gillies McKenna, Francesca Meteora Buffa et al. · 2017 · Cancer Research
75. Reprogramming Suppresses Premature Senescence Phenotypes of Werner Syndrome Cells and Maintains Chromosomal Stability over Long-Term Culture
    Akira Shimamoto, Harunobu Kagawa, Zensho Kazumasa, Yukihiro Sera, Yasuhiro Kazuki, Mitsuhiko Osaki, Mitsuo Oshimura, Yasuhito Ishigaki, K. Hamasaki, Yoshiaki Kodama et al. · 2014 · PLoS ONE
76. The molecular mechanisms underlying the therapeutic resistance of cancer stem cells
    Jun-Kyum Kim, Hee-Young Jeon, Hyunggee Kim · 2014 · Archives of Pharmacal Research
77. Selective elimination of leukemia stem cells: Hitting a moving target
    Leslie A. Crews, Catriona H. M. Jamieson · 2012 · Cancer Letters
78. Thymic Function Associated With Cancer Development, Relapse, and Antitumor Immunity – A Mini-Review
    Weikan Wang, Rachel G. Thomas, Olga S. Sizova, Dong‐Ming Su · 2020 · Frontiers in Immunology
79. CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer
    Wenxia Xu, Qi Wei, Mengjiao Han, Bingluo Zhou, Hanying Wang, Jianbing Zhang, Qiang Wang, Jie Sun, Lifeng Feng, Shouyu Wang et al. · 2018 · International Journal of Biological Sciences
80. LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer
    Su-Yan WANG, Zhengzhi Zou, X Luo, Yanjun Mi, Haocai Chang, Da Xing · 2018 · Oncogene
81. Senescence and cancer: An evolving inflammatory paradox
    Megan K. Ruhland, Lisa M. Coussens, Sheila A. Stewart · 2015 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
82. The Dual Role of Mesenchymal Stem Cells in Cancer Pathophysiology: Pro-Tumorigenic Effects versus Therapeutic Potential
    Slama, Youssef, Ah-Pine, Franck, Khettab, Mohamed, Arcambal, Angelique, Begue, Mickael, Dutheil, Fabien, Gasque, Philippe · 2023 · International Journal of Molecular Sciences
83. Senescence and tumor suppression
    Philip W. Hinds, Jodie R. Pietruska · 2017 · F1000Research
84. DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance
    Roland M. Huber, Jared M. Lucas, Luis Gomez-Sarosi, Ilsa M. Coleman, Song Q Zhao, ROGER T. COLEMAN, Peter S. Nelson · 2014 · Oncotarget
85. Cytotoxic Chemotherapy and CD4+ Effector T Cells: An Emerging Alliance for Durable Antitumor Effects
    Zhi‐Chun Ding, Gang Zhou · 2012 · Clinical and Developmental Immunology
86. Genetic instability in the tumor microenvironment: a new look at an old neighbor
    Antônio Palumbo, Nathalia Meireles Da Costa, Martín Bonamino, Luís Felipe Ribeiro Pinto, Luiz Eurico Nasciutti · 2015 · Molecular Cancer
87. Chemotherapeutic Resistance: Surviving Stressful Situations
    Luke A. Gilbert, Michael T. Hemann · 2011 · Cancer Research
88. Cytokine-mediated therapeutic resistance in breast cancer
    Chunli Tan, Weizi Hu, Yunjie He, Yanyan Zhang, Guangqin Zhang, Yong Xu, Jinhai Tang · 2018 · Cytokine
89. Dark Side of Cytotoxic Therapy: Chemoradiation-Induced Cell Death and Tumor Repopulation
    Mingjie Jiang, Dian-na Gu, Juanjuan Dai, Qian Huang, Ling Tian · 2020 · Trends in cancer
90. Chemotherapy counteracted
    Urban Emmenegger, Robert S. Kerbel · 2010 · Nature
91. A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors
    Haihong Zhong, April Davis, Maria Ouzounova, Rosa A. Carrasco, Cui Chen, Shannon Breen, Yong Seok Chang, Jiaqi Huang, Zheng Liu, Yihong Yao et al. · 2016 · Cancer Research
92. Cellular senescence in the tumor microenvironment and context‐specific cancer treatment strategies
    Tadahito Yasuda, Hideo Baba, Takatsugu Ishimoto · 2021 · FEBS Journal
93. Cytokines chattering in pancreatic ductal adenocarcinoma tumor microenvironment
    Rakesh Bhatia, Namita Bhyravbhatla, Andrew Kisling, Xiaoqi Li, Surinder K. Batra, Sushil Kumar K · 2022 · Seminars in Cancer Biology
94. The pro‐metastatic role of bone marrow‐derived cells: a focus on MSCs and regulatory T cells
    Bong Ihn Koh, Yibin Kang · 2012 · EMBO Reports
95. Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer
    Julia Kallenbach, Golnaz Atri Roozbahani, Mehdi Heidari Horestani, Aria Baniahmad · 2022 · Cell & Bioscience
96. Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence
    Andrea Walens, Jiaxing Lin, Jeffrey S. Damrauer, Brock J. McKinney, Ryan Lupo, Rachel Newcomb, Douglas B. Fox, Nathaniel W. Mabe, Jeremy S. Gresham, Zhecheng Sheng et al. · 2020 · Nature Communications
97. Non-Hodgkin’s B-cell lymphoma: Advances in molecular strategies targeting drug resistance
    Steven A. Maxwell, Seyed Mousavi-Fard · 2013 · Experimental Biology and Medicine
98. Towards Curative Cancer Immunotherapy: Overcoming Posttherapy Tumor Escape
    Gang Zhou, Hyam I. Levitsky · 2012 · Clinical and Developmental Immunology
99. CXCR4 as a prognostic biomarker in gastrointestinal cancer: a meta-analysis
    Qingtao Jiang, Yun Tian Sun, Xin Liu · 2019 · Biomarkers
100. The IL-6R and Bmi-1 axis controls self-renewal and chemoresistance of head and neck cancer stem cells
     Alexandra E. Herzog, Kristy A. Warner, Zhaocheng Zhang, Emily Light Bellile, Meera A. Bhagat, ROGERIO MORAES CASTILHO, Gregory T. Wolf, Peter J. Polverini, Alexander T. Pearson, Jacques Eduardo Nor · 2021 · Cell Death and Disease